 |
PDBsum entry 2ql6
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein,transferase
|
PDB id
|
|
|
|
2ql6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein,transferase
|
 |
|
Title:
|
 |
Human nicotinamide riboside kinase (nrk1)
|
|
Structure:
|
 |
Nicotinamide riboside kinase 1. Chain: a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p. Synonym: nrk1. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: nrk1, c9orf95. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.70Å
|
R-factor:
|
0.207
|
R-free:
|
0.235
|
|
|
Authors:
|
 |
J.A.Khan,S.Xiang,L.Tong
|
Key ref:
|
 |
J.A.Khan
et al.
(2007).
Crystal structure of human nicotinamide riboside kinase.
Structure,
15,
1005-1013.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Jul-07
|
Release date:
|
02-Oct-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q9NWW6
(NRK1_HUMAN) -
Nicotinamide riboside kinase 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
199 a.a.
179 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.7.1.173
- nicotinate riboside kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
beta-D-ribosylnicotinate + ATP = nicotinate beta-D-ribonucleotide + ADP + H+
|
 |
 |
 |
 |
 |
beta-D-ribosylnicotinate
|
+
|
ATP
|
=
|
nicotinate beta-D-ribonucleotide
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.2.7.1.22
- ribosylnicotinamide kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
beta-nicotinamide D-riboside + ATP = beta-nicotinamide D-ribonucleotide + ADP + H+
|
 |
 |
 |
 |
 |
beta-nicotinamide D-riboside
|
+
|
ATP
|
=
|
beta-nicotinamide D-ribonucleotide
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Structure
15:1005-1013
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human nicotinamide riboside kinase.
|
|
J.A.Khan,
S.Xiang,
L.Tong.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Nicotinamide riboside kinase (NRK) has an important role in the biosynthesis of
NAD(+) as well as the activation of tiazofurin and other NR analogs for
anticancer therapy. NRK belongs to the deoxynucleoside kinase and nucleoside
monophosphate (NMP) kinase superfamily, although the degree of sequence
conservation is very low. We report here the crystal structures of human NRK1 in
a binary complex with the reaction product nicotinamide mononucleotide (NMN) at
1.5 A resolution and in a ternary complex with ADP and tiazofurin at 2.7 A
resolution. The active site is located in a groove between the central parallel
beta sheet core and the LID and NMP-binding domains. The hydroxyl groups on the
ribose of NR are recognized by Asp56 and Arg129, and Asp36 is the general base
of the enzyme. Mutation of residues in the active site can abolish the catalytic
activity of the enzyme, confirming the structural observations.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. The Binding Modes of NMN and Tiazofurin (A)
The binding site for NMN. Hydrogen-bonding interactions are
indicated with blue, dashed lines. The binding mode of
tiazofurin is also shown (in black). (B) Molecular surface
of the active-site region of NRK1, colored based on
electrostatic potential. (C) Final 2F[o] − F[c] electron
density for tiazofurin at 2.7 Å resolution. Contoured at
1σ. (A) and (C) were produced with PyMOL (DeLano, 2002);
(B) was produced with Grasp (Nicholls et al., 1991).
|
 |
Figure 5.
Figure 5. The Binding Mode of ADP (A) Final 2F[o] −
F[c] electron density for ADP at 2.7 Å resolution.
Contoured at 1σ. (B) The binding site for ADP.
Hydrogen-bonding interactions are indicated with blue, dashed
lines. (C) Overlay of the structures of the binary complex
with NMN (in gray) and the ternary complex with ADP:tiazofurin.
This figure was produced with PyMOL (DeLano, 2002).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(2007,
15,
1005-1013)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Bi,
H.Wang,
and
J.Xie
(2011).
Comparative genomics of NAD(P) biosynthesis and novel antibiotic drug targets.
|
| |
J Cell Physiol,
226,
331-340.
|
 |
|
|
|
|
 |
K.Maiese,
Y.C.Shang,
Z.Z.Chong,
and
J.Hou
(2010).
Diabetes mellitus: channeling care through cellular discovery.
|
| |
Curr Neurovasc Res,
7,
59-64.
|
 |
|
|
|
|
 |
K.Maiese,
Z.Z.Chong,
J.Hou,
and
Y.C.Shang
(2009).
The vitamin nicotinamide: translating nutrition into clinical care.
|
| |
Molecules,
14,
3446-3485.
|
 |
|
|
|
|
 |
Y.Araiso,
R.L.Sherrer,
R.Ishitani,
J.M.Ho,
D.Söll,
and
O.Nureki
(2009).
Structure of a tRNA-dependent kinase essential for selenocysteine decoding.
|
| |
Proc Natl Acad Sci U S A,
106,
16215-16220.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |